SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.400
-0.080 (-2.30%)
At close: Jun 3, 2026, 4:00 PM EDT
3.360
-0.040 (-1.18%)
After-hours: Jun 3, 2026, 4:04 PM EDT
SAB Biotherapeutics Employees
SAB Biotherapeutics had 86 employees as of December 31, 2025. The number of employees increased by 23 or 36.51% compared to the previous year.
Employees
86
Change (1Y)
23
Growth (1Y)
36.51%
Revenue / Employee
n/a
Profits / Employee
-$109,428
Market Cap
238.94M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 86 | 23 | 36.51% |
| Dec 31, 2024 | 63 | 6 | 10.53% |
| Dec 31, 2023 | 57 | 1 | 1.79% |
| Dec 31, 2022 | 56 | -83 | -59.71% |
| Mar 31, 2022 | 148 | 62 | 72.09% |
| Dec 31, 2021 | 139 | 53 | 61.63% |
| Sep 30, 2021 | 143 | 57 | 66.28% |
| Jun 30, 2021 | 137 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Entrada Therapeutics | 152 |
| LENZ Therapeutics | 152 |
| Codexis | 146 |
| Coherus Oncology | 145 |
| Adagene | 128 |
| AC Immune | 122 |
| Foghorn Therapeutics | 106 |
| Caribou Biosciences | 97 |
SABS News
- 5 days ago - SAB BIO to Present Data on SAB-142 at The American Diabetes Association's 2026 Scientific Sessions and FOCIS 2026 Annual Meeting - GlobeNewsWire
- 12 days ago - SAB Biotherapeutics initiated with a Buy at Citi - TheFly
- 14 days ago - SAB Biotherapeutics initiated with a Buy at Jefferies - TheFly
- 21 days ago - SAB Biotherapeutics Slides: Corporate presentation - Filings
- 22 days ago - SAB Biotherapeutics price target raised to $10 from $7 at H.C. Wainwright - TheFly
- 22 days ago - SAB Biotherapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 22 days ago - SAB Biotherapeutics Earnings release: Q1 2026 - Filings
- 22 days ago - SAB Biotherapeutics Quarterly report: Q1 2026 - Filings